Ali S Alzahrani

27PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedEpigenetics (incl. genome methylation and epigenomics)Genetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 01, 2026
Exceptional and Durable Response to Selpercatinib in a Patient with Apparently RET-Negative, HRAS-, and NF1-Mutated Metastatic Medullary Thyroid Carcinoma.

|Aug 21, 2026
Octreotide as Adjunctive Therapy for Catecholamine-Secreting Pheochromocytoma and Paraganglioma.

|Aug 03, 2026
Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.

|May 21, 2026
SDHB-associated paraganglioma in Saudi Arabia: High metastatic risk linked to a likely founder mutation.

|Feb 02, 2026
Molecular Genetics of 1α-Hydroxylase Deficiency in the Saudi Population.

Bassam Bin-Abbas, Afaf Alsagheir, Balgees Alghamdi

|Jan 30, 2026
A novel germline CDH23 variant as a likely cause of an ultra-giant prolactinoma.

Eman Albasri, Balgees Alghamdi, Avaniyapuram Kannan Murugan

Pageof 5

Frequent Collaborators

3 joint publications

Yufei Shi

1 joint publications

Budoor Alemadi

1 joint publications

R Michael Tuttle

1 joint publications

Yousif H Al-Malki